Astrazencea Pharma India has surged 9% to Rs 813 after the company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The pharmaceutical company had loss of Rs 33.01 crore in a year ago quarter.
“Net sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012,” Astrazencea Pharma India said in statement.
During the quarter under review, staff cost has declined by 36% to Rs 36.82 crore from Rs 57.91 crore in the corresponding quarter of previous year.
The stock opened at Rs 768 and hit a high of Rs 867 on NSE. The counter have seen huge trading activity with a combined 576,470 shares changing hands till 1158 hours compare to an average sub 65,000 shares that were traded daily in past two weeks on NSE and BSE.
“Net sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012,” Astrazencea Pharma India said in statement.
During the quarter under review, staff cost has declined by 36% to Rs 36.82 crore from Rs 57.91 crore in the corresponding quarter of previous year.
The stock opened at Rs 768 and hit a high of Rs 867 on NSE. The counter have seen huge trading activity with a combined 576,470 shares changing hands till 1158 hours compare to an average sub 65,000 shares that were traded daily in past two weeks on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%